SFO - Longevity Life Sciences ©
What would you do with more life in your lifetime? We’re on a mission to find out.
- SFO - Longevity Life Sciences © is a privately held research and development company founded by SFO. Our mission is to harness advanced technologies and model systems to deepen our understanding of the biology that controls human aging. We aim to use this knowledge to develop interventions that enable people to live longer, healthier lives, effectively combating and even reversing the diseases of aging.
- Unlike traditional biotechnology companies or academic institutions, we combine the best aspects of both, free from their typical constraints. We ask the difficult questions about aging and the associated diseases, requiring a long-term perspective, relentless focus, state-of-the-art technology, advanced computing capabilities, and a strong culture and values guiding our decisions.
Our Progress
- The desire to conquer aging is ancient. Humans have always been fascinated by the idea of defying death, looking to religion, the stars, cryogenics, and even the mythical fountain of youth. While exploring these avenues, we discovered that the secret to immortality might have been in the ocean all along—in the form of a jellyfish.
- Using an integrated model, we cover the entire aging market with various advanced therapeutic interventions targeting the biology of aging to treat multiple conditions. Our ultimate goal is to therapeutically target aging itself and extend the human lifespan. Two decades ago, we aimed to shift the focus from curing sickness to maintaining perpetual wellness. We have moved beyond hope and promise to realizing our vision, aiming to make 90 years the new 50 by 2030.
Our Patents
- Functional Longevity: Drugs and treatments that maintain functionality and freedom from age-associated diseases.
- Cellular Transdifferentiation: Techniques to transform senescent cells, which cease dividing as humans age.
- Enhanced Cell Plasticity: Methods to increase cells' ability to change phenotypes without genetic mutations in response to environmental cues.
- Repurposing Junk DNA: Classifying exons and introns as “intragenic” and other elements as “intergenic.”
- Gene Regulation: Genetic and epigenetic mechanisms to regulate aging-related gene activity in real-time without altering DNA sequences.
- Understanding Living Systems: Advances toward understanding living systems and extending human life.
- Restoring Cellular Functions: Techniques to restore functions lost in older cells.
- Proteome Diversification: Understanding tissue fate and function through proteome diversification.
- Cellular Rejuvenation: Programs to restore cell health and resilience, developing life-extending therapies.
- Molecular Biomarkers: Highly accurate biomarkers for aging.
- AI and Machine Learning: Using AI, machine learning, and data to improve efficiencies in developing therapeutics for longevity.
- Stem Cells and Cloning: Research on cellular aging, cloning, and telomerase.
- Regenerative Medicines: Developing medicines to restore youthful regenerative capacity, treating age-related diseases and regenerating tissues.
- Cryogenics: Advances in cryogenics.
We have many more patents in the pipeline. ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■
Copyright © SFO Media & Entertainment Ltd. (Part of SFO Group). All rights reserved. Reproduction of news articles, photos, videos, or any other content in whole or in part in any form or medium without express written permission from sekhonfamilyoffice.com is prohibited.